| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_40765ca9a78b54a8a76f781d159ad145 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-06 |
| filingDate |
2002-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2003-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f839f145a91ce6b1c0e4fa0651454ac6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de7d0e6077a972614742e35a860cdfb8 |
| publicationDate |
2003-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-6512106-B2 |
| titleOfInvention |
Nucleoside modifications by palladium catalyzed methods |
| abstract |
This invention discloses a method for the preparation of 2′-modified nucleosides, using a palladium catalyst and an alkene functionalized with a heteroatom. Included in the invention are the novel pyrimidines and purines that can be prepared according to the method of the invention and oligonucleotides containing said modified pyrimidines and purines. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6846918-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004034212-A1 |
| priorityDate |
1998-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |